Biohit, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. Its diagnostic tests product range includes the blood-sample based GastroPanel test for diagnosing diseases of the stomach and associated risks; quick tests for the diagnosis of lactose intolerance, Helicobacter pylori infection, and Celiac disease; and ColonView for the early detection of fecal occult blood. The Company's diagnostic tests are also used for the identification of patients at increased risk of gastric cancer, peptic ulcer disease, and gastroesophageal reflux disease, as well as deficiencies of vitamin B12, calcium, and iron.
Market capitalization (27-Apr-2020)
Closing stock price (27-Apr-2020)
Biohit has 552 Twitter Followers. The number of followers has increased 0.7% month over month and increased 1.5% quarter over quarter
When was Biohit founded?
Biohit was founded in 1988.
Who are Biohit key executives?
Biohit's key executives are Semi Korpela and Ilari Patrakka.
How many employees does Biohit have?
Biohit has 51 employees.
Who are Biohit competitors?
Competitors of Biohit include Sartorius, Response Biomedical and Laboratory Corporation of America Holdings.
Where is Biohit headquarters?
Biohit headquarters is located at Laippatie 1, Helsinki.
Where are Biohit offices?
Biohit has offices in Helsinki, Milano and Cheshire.
How many offices does Biohit have?
Biohit has 3 offices.
Receive alerts for 300+ data fields across thousands of companies